Cel Sci R&D Spending Growth & History (CVM)
Cel Sci's r&d spending was $15.9M for fiscal 2025.
View full Cel Sci company overviewCel Sci annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $15.9M | −$2.3M | −12.52% |
| 2024 | 2024-09-30 | $18.2M | −$4.3M | −19.18% |
| 2023 | 2023-09-30 | $22.5M | −$2.9M | −11.37% |
| 2022 | 2022-09-30 | $25.4M | $2.2M | +9.72% |
| 2021 | 2021-09-30 | $23.1M | $5.3M | +29.53% |
| 2020 | 2020-09-30 | $17.8M | $5.2M | +40.93% |
| 2019 | 2019-09-30 | $12.7M | $1.7M | +15.99% |
| 2018 | 2018-09-30 | $10.9M | −$4.7M | −30.07% |
| 2017 | 2017-09-30 | $15.6M | −$1.8M | −10.54% |
| 2016 | 2016-09-30 | $17.4M | −$1.7M | −9.10% |
| 2015 | 2015-09-30 | $19.2M | $3.9M | +25.71% |
| 2014 | 2014-09-30 | $15.3M | $2.6M | +20.39% |
| 2013 | 2013-09-30 | $12.7M | $2.3M | +22.30% |
| 2012 | 2012-09-30 | $10.4M | −$1.4M | −11.72% |
| 2011 | 2011-09-30 | $11.7M | −$165,997 | −1.39% |
| 2010 | 2010-09-30 | $11.9M | $5.9M | +98.14% |
| 2009 | 2009-09-30 | $6.0M | — | — |
Cel Sci quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $3.6M | −$90,008 | −2.41% |
| Q2 2026 | 2026-03-31 | $3.8M | −$247,350 | −6.16% |
| Q1 2026 | 2025-12-31 | $3.7M | −$752,833 | −16.99% |
| Q4 2025 | 2025-09-30 | $3.7M | −$774,546 | −17.30% |
| Q3 2025 | 2025-06-30 | $3.7M | −$963,212 | −20.48% |
| Q2 2025 | 2025-03-31 | $4.0M | −$614,270 | −13.27% |
| Q1 2025 | 2024-12-31 | $4.4M | $77,554 | +1.78% |
| Q4 2024 | 2024-09-30 | $4.5M | −$790,426 | −15.01% |
| Q3 2024 | 2024-06-30 | $4.7M | −$1.0M | −17.89% |
| Q2 2024 | 2024-03-31 | $4.6M | −$1.5M | −23.92% |
| Q1 2024 | 2023-12-31 | $4.4M | −$1.0M | −19.29% |
| Q4 2023 | 2023-09-30 | $5.3M | −$1.2M | −18.48% |
| Q3 2023 | 2023-06-30 | $5.7M | −$559,084 | −8.89% |
| Q2 2023 | 2023-03-31 | $6.1M | −$440,329 | −6.75% |
| Q1 2023 | 2022-12-31 | $5.4M | −$690,621 | −11.35% |
| Q4 2022 | 2022-09-30 | $6.5M | $1.2M | +22.13% |
| Q3 2022 | 2022-06-30 | $6.3M | −$895,226 | −12.46% |
| Q2 2022 | 2022-03-31 | $6.5M | $1.3M | +24.94% |
| Q1 2022 | 2021-12-31 | $6.1M | $668,407 | +12.34% |
| Q4 2021 | 2021-09-30 | $5.3M | $130,664 | +2.53% |
| Q3 2021 | 2021-06-30 | $7.2M | $3.2M | +80.95% |
| Q2 2021 | 2021-03-31 | $5.2M | $762,967 | +17.11% |
| Q1 2021 | 2020-12-31 | $5.4M | $1.2M | +27.32% |
| Q4 2020 | 2020-09-30 | $5.2M | $1.8M | +52.23% |
| Q3 2020 | 2020-06-30 | $4.0M | $1.0M | +33.84% |
| Q2 2020 | 2020-03-31 | $4.5M | $1.6M | +57.40% |
| Q1 2020 | 2019-12-31 | $4.3M | $781,099 | +22.50% |
| Q4 2019 | 2019-09-30 | $3.4M | $188,857 | +5.90% |
| Q3 2019 | 2019-06-30 | $3.0M | $539,950 | +22.26% |
| Q2 2019 | 2019-03-31 | $2.8M | −$129,751 | −4.38% |
| Q1 2019 | 2018-12-31 | $3.5M | $1.1M | +49.26% |
| Q4 2018 | 2018-09-30 | $3.2M | $900,949 | +39.18% |
| Q3 2018 | 2018-06-30 | $2.4M | −$754,839 | −23.73% |
| Q2 2018 | 2018-03-31 | $3.0M | −$3.6M | −54.97% |
| Q1 2018 | 2017-12-31 | $2.3M | −$1.2M | −34.45% |
| Q4 2017 | 2017-09-30 | $2.3M | −$1.9M | −45.75% |
| Q3 2017 | 2017-06-30 | $3.2M | −$1.2M | −27.08% |
| Q2 2017 | 2017-03-31 | $6.6M | $2.4M | +58.45% |
| Q1 2017 | 2016-12-31 | $3.5M | −$1.1M | −24.39% |
| Q4 2016 | 2016-09-30 | $4.2M | $706,059 | +19.99% |
| Q3 2016 | 2016-06-30 | $4.4M | −$1.4M | −23.85% |
| Q2 2016 | 2016-03-31 | $4.2M | −$924,446 | −18.21% |
| Q1 2016 | 2015-12-31 | $4.7M | −$161,913 | −3.34% |
| Q4 2015 | 2015-09-30 | $3.5M | $894,003 | +33.88% |
| Q3 2015 | 2015-06-30 | $5.7M | $1.3M | +28.60% |
| Q2 2015 | 2015-03-31 | $5.1M | $922,431 | +22.21% |
| Q1 2015 | 2014-12-31 | $4.9M | $835,280 | +20.78% |
| Q4 2014 | 2014-09-30 | $2.6M | −$832,284 | −23.98% |
| Q3 2014 | 2014-06-30 | $4.5M | $684,192 | +18.15% |
| Q2 2014 | 2014-03-31 | $4.2M | $1.6M | +65.13% |
| Q1 2014 | 2013-12-31 | $4.0M | $1.1M | +37.43% |
| Q4 2013 | 2013-09-30 | $3.5M | $622,095 | +21.83% |
| Q3 2013 | 2013-06-30 | $3.8M | $1.3M | +52.66% |
| Q2 2013 | 2013-03-31 | $2.5M | −$78,650 | −3.03% |
| Q1 2013 | 2012-12-31 | $2.9M | $468,537 | +19.08% |
| Q4 2012 | 2012-09-30 | $2.8M | $334,776 | +13.31% |
| Q3 2012 | 2012-06-30 | $2.5M | −$455,605 | −15.58% |
| Q2 2012 | 2012-03-31 | $2.6M | −$447,862 | −14.72% |
| Q1 2012 | 2011-12-31 | $2.5M | −$808,243 | −24.76% |
| Q4 2011 | 2011-09-30 | $2.5M | — | — |
| Q3 2011 | 2011-06-30 | $2.9M | $1.3M | +84.24% |
| Q2 2011 | 2011-03-31 | $3.0M | — | — |
| Q1 2011 | 2010-12-31 | $3.3M | — | — |
| Q3 2010 | 2010-06-30 | $1.6M | — | — |
Cel Sci r&d spending trends
Over the last five fiscal years, Cel Sci's r&d spending decreased from $17.8M to $15.9M, a change of −$2.0M. The latest reported quarter, Q3 2026, shows $3.6M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cel Sci source filings ↗